Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan · Delayed Price · Currency is TWD 78.90
-0.30 (-0.38%)
Aug 19, 2026, 9:38 AM CST
Foresee Pharmaceuticals Market Cap
Foresee Pharmaceuticals has a market cap or net worth of 12.48 billion as of August 18, 2026. Its market cap has increased by 3.43% in one year.
Market Cap
12.48B
Enterprise Value
11.60B
Revenue
471.13M
Ranking
n/a
PE Ratio
554.64
Stock Price
78.90
ChartMarket Cap Chart
Since April 12, 2016, Foresee Pharmaceuticals's market cap has increased from 7.35B to 12.48B, an increase of 69.73%. That is a compound annual growth rate of 5.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 12.48B | -1.74% |
| Dec 31, 2025 | 12.70B | 5.86% |
| Dec 31, 2024 | 12.00B | -8.16% |
| Dec 29, 2023 | 13.06B | 20.98% |
| Dec 30, 2022 | 10.80B | -23.14% |
| Dec 30, 2021 | 14.05B | 34.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Center Laboratories | 24.96B |
| TTY Biopharm Company | 18.92B |
| Synmosa Biopharma | 16.19B |
| ScinoPharm Taiwan | 15.02B |
| YungShin Global Holding | 14.46B |
| Grape King Bio | 13.42B |
| Handa Pharmaceuticals | 12.86B |
| Standard Chemical & Pharmaceutical | 10.99B |